SARS-CoV-2 nsp14-IN-11 (Compound 13) is a NSP14 exonuclease inhibitor (pIC50 = 4.4). SARS-CoV-2 nsp14-IN-11 shows robust and complete NSP14 exonuclease inhibition. SARS-CoV-2 nsp14-IN-11 can be used in the research of SARS-CoV-2 infection[1].
Molecular Weight:
319.38
Formula:
C14H17N5O2S
Target:
SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted